Search results
- 1.1150Add to watchlist+0.0250 (+2.29%)As of Mon. Jul 8, 2024 1:49 PM EDT · Nasdaq Real Time Price (USD) · Market open
- Open1.1100High1.1400Low1.1100
- Mkt Cap33.06MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close1.090052 Wk. Low1.050052 Wk. High11.0600
Related stocks
Find the latest Immuneering Corporation (IMRX) stock quote, history, news and other vital information to help you with your stock trading and investing.
View Immuneering Corp. Class A IMRX stock quote prices, financial information, real-time forecasts, and company news from CNN.
Jun 27, 2024 · IMRX | Complete Immuneering Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
- 5.44%
- 5.44%
- 78.48%
- 81.09%
3 days ago · A high-level overview of Immuneering Corporation (IMRX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
- Carisma Therapeutics, Inc.
- Biotechnology
- 107
- 42.37M
People also ask
What does imrx stand for?
Where is imrx based?
What is an IMR or IMX score?
Does imrx have company insights?
Get the latest Immuneering Corp (IMRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Immuneering is a clinical-stage oncology company developing universal-RAS/RAF medicines for various cancers. See its latest stock price, news, financial results, and analyst ratings on Stock Analysis.
Immuneering Corporation Class A Common Stock (IMRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.